Chinese Stocks on Radar After Stimulus Boost

Chinese stocks could be set for a recovery after recent stimulus talk, according to Goldman Sachs.

CH50: Weekly Chart

CH50: Weekly Chart

The CH 50 rallied this week, and that gives hope that the market can break higher above the triangle formation resistance at 13,200–13,600.

Global hedge funds bought Chinese equities after this week’s Politburo meeting at their fastest pace since October 2022, Goldman Sachs said.

The highest inflows were to the CH 50 and Hong Kong-listed shares, while US-listed Chinese American Depositary Receipts (ADRs), mainly internet companies, saw smaller inflows, the report added.

Chinese policymakers unveiled further measures to improve investment in infrastructure sectors, while planners said they would provide financing for private projects. The sectors most affected included consumer, financial, materials, and industrial.

Global investors have been pulling back from China over the last few months after the country’s economy saw a slower recovery than analysts expected. That was joined by tensions with the United States.

The investment bank said hedge funds’ exposure to Chinese equities was still around the low levels last seen in November 2022 and well below five-year averages. There are now signs that sentiment is picking up with net foreign buying on the mainland. Chinese equities recorded 20 billion yuan this month, their best month since April, official data showed.

Recent News
Start Trading Now !

Try our demo account for free to learn trading. When you’re ready, switch to a live account and start trading for real.

Popular posts
ATFX

Restrictions on Use

Products and Services on this website are not available for Hong Kong investors and not related to any corporation licensed by the Securities and Futures Commission in Hong Kong.

All the information and materials posted on this website should not be regarded as or constitute a distribution, an offer, solicitation to buy or sell any investments.

使用限制:本網站的產品及服務不適用於香港投資者及與任何香港證監會持牌公司無關。

網站內部的信息和素材不應被視為分銷,要約,買入或賣出任何投資產品。